Global Nerve Thrombectomy Device Market Key Insights Based on Product Type, End-use and Regional Demand

SDKI Inc. published a new report on the nerve thrombectomy device market. This study includes the statistical and analytical approaches needed to grow the neurothrombosis device market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111621

The market for neurothrombosis equipment is estimated to reach US $ 1,064.4 million by 2030 from a market value of US $ 684.9 million in 2022 and is expected to grow at a CAGR of 6.5% during the 2022-2030 forecast period. It has been.

The neurothrombus resection device aims to recover or destroy thrombi in the cranial nerve vasculature. Approved by the Food and Drug Administration (FDA) as a device. This is done by mechanical, ultrasonic technology, laser, or a combination of technologies. This drug helps reduce patient mortality. Increasing stroke rates and the growing elderly population around the world are key drivers of the growth of the neurothrombosis device market during the forecast period.

According to the United Nations Department of Economic and Social Affairs, the world's population aged 65 and over will be 703 million in 2019, and is projected to double by 2050 to 1.5 billion. Similarly, according to Statista, the American population of the elderly (aged 65 and over) was 16% in 2018 and is expected to increase by 22% in 2050. Therefore, an increasing elderly population and an increasing incidence of stroke around the world will drive the growth of the neurothrombosis equipment market during the forecast period. However, the risks associated with the neurothrombosis procedure may curb the growth of the global neurothrombosis device market during the forecast period.

Nerve Thrombectomy Device Market Segment

The Nerve Thrombectomy Device Market is divided by product (clot recovery device, suction / suction device and vascular snare), end use (hospital, emergency clinic and outpatient surgery center), and region. increase. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL
https://www.sdki.jp/sample-request-111621

Regional overview of the nerve thrombectomy device market

The European region is the world's leading region in terms of market share. This is due to the rapid adoption of new technologies and the increasing number of patients suffering from acute ischemic stroke. In addition, the presence of well-developed medical facilities and favorable reimbursement policies have contributed to the growth of the neurothrombosis equipment market in the region. Meanwhile, the Asia Pacific neurothrombosis equipment market is also expected to show the highest growth rate / CAGR during the 2022-2030 forecast period.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Key Players

Nerve Thrombectomy Device Market Key players in the Nerve Thrombectomy Device Market include Medtronic plc, Stryker Corporation, Acandis GmbH, Phenox GmbH, Penumbra Inc. and Vescalio. The study includes a detailed competitive analysis, corporate profile, recent developments, and key market strategies for these major companies in the neurothrombosis equipment market.

Details of the survey report
https://www.sdki.jp/press-details/neurothrombectomy-devices-market/340

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.